Intermountain Healthcare Partners With the University of Utah to Create Academic Program to Help Keep People Healthy

    NEXT STORY
    Microplate Reader Market Value Worth $704.4 Million by 2027, Says The Insight Partners – Impact of COVID-19 Pandemic and Global Analysis
    PREV STORY
    Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    UCLA Study Links Healthwise® Shared Decision Making Tools to Better Clinical Outcomes in Diabetes Patients

    author_avatar
    NASDAQ Market News

    Cempra Presents Analysis Showing Rates of Failure for Existing CABP Antibiotics From Claims Database at Academy of Managed Care Pharmacy Meeting

    —More than 20 percent of adult CABP patients failed initial antibiotic monotherapy, including approximately ...

    author_avatar
    NASDAQ Market News

    Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2017 Financial Results

    NEWTOWN, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

    author_avatar
    NASDAQ Market News